Klaus Berger

Klaus Berger is affiliated with James Cook University, contributing to interdisciplinary research at the intersection of psychiatry, neurology, and genetics. His work focuses on mental health disorders, cardiovascular comorbidities, neuroimaging techniques, and genetic risk factors. Key areas of investigation include the biological underpinnings of depression, bipolar disorder treatment responses, and the role of inflammatory markers in disease progression.

Research emphasizes the MEMO Study cohort for aging-related brain changes and cognitive function. Collaboration with institutions globally highlights his contributions to meta-analyses on stroke genetics (METASTROKE) and randomized controlled trials in nephrology. Publications span Molecular Psychiatry, Lancet Neurology, and Neurobiology of Aging, reflecting a strong translational research profile.

Publications demonstrate expertise in neuroimaging analysis (e.g., MRI segmentation, Hidden Markov modeling), pharmacogenetics, and systematic reviews on depression-cardiovascular links. His work bridges basic science (genetic studies) and clinical practice (treatment response evaluation).